# Vedantra Pharmaceuticals, Inc. — Form D

Vedantra Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2012-07-31. The offering totals $5.0M, of which $3.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2012-07-31
- Form: D
- Accession: 0001140361-12-034377
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $5.0M
- Amount sold: $3.3M
- Remaining: $1.7M
- Investors: 1
- Security types: equity
- Revenue range: Decline to Disclose

## Issuer

- Name: Vedantra Pharmaceuticals, Inc.
- CIK: 0001555192
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: ONE BROADWAY, CAMBRIDGE, MA, 02142
- Phone: 617-360-9995

## Officers, directors & promoters (25)

| Name | Role | Location |
| --- | --- | --- |
| Daniel Behr | Director | Westborough, MA |
| Ben Bronstein | Director | Westborough, MA |
| Alan Shaw | Director | Cambridge, MA |
| Alan Shaw | Executive Officer | Cambridge, MA |
| Alan Shaw | Promoter | Cambridge, MA |
| Yekaterina Chudnovsky | Director | LOS ANGELES, CA |
| Christopher Haqq | Executive Officer | Boston, MA |
| Carol Ashe | Director | Boston, MA |
| Robert Connelly | Director | Boston, MA |
| Robert Connelly | Executive Officer | Boston, MA |
| Robert Ruffolo | Director | Boston, MA |
| Julian Adams | Director | Boston, MA |
| Julian Adams | Executive Officer | Boston, MA |
| Annette Matthies | Executive Officer | Boston, MA |
| Assaf Segal | Director | Boston, MA |
| Daniel Geffken | Director | Boston, MA |
| Daniel Geffken | Executive Officer | Boston, MA |
| Daphne Karydas | Director | Brooklyn, NY |
| Ofer Gonen | Director | Yavne, L3 |
| Isaac Kohlberg | Director | Cambridge, MA |
| Frank Haluska | Director | Cambridge, MA |
| Isaac Blech | Director | Jupiter, FL |
| William Koster | Director | Westborough, MA |
| Satish Jindal | Director | Cleveland, OH |
| Steve Deitcher | Director | Cambridge, MA |

## Other filings by this issuer (12)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-11-02](https://search.stillhousedata.com/formd/0001555192-22-000002) | D/A | $50.0M | $22.0M |
| [2022-05-27](https://search.stillhousedata.com/formd/0001555192-22-000001) | D | $50.0M | $975K |
| [2021-11-18](https://search.stillhousedata.com/formd/0001555192-21-000003) | D/A | $15.0M | $14.5M |
| [2021-11-12](https://search.stillhousedata.com/formd/0001555192-21-000002) | D/A | $15.0M | $14.5M |
| [2021-10-19](https://search.stillhousedata.com/formd/0001555192-21-000001) | D | $15.0M | $2.0M |
| [2020-07-15](https://search.stillhousedata.com/formd/0001567619-20-013296) | D | $30.0M | $6.1M |
| [2020-03-13](https://search.stillhousedata.com/formd/0001567619-20-006266) | D | $8.4M | $8.4M |
| [2019-10-15](https://search.stillhousedata.com/formd/0001567619-19-019555) | D | $7.0M | $7.0M |
| [2018-09-14](https://search.stillhousedata.com/formd/0001567619-18-002672) | D | $36.2M | $25.8M |
| [2018-08-03](https://search.stillhousedata.com/formd/0001140361-18-035317) | D | $14.5M | $14.5M |
| [2018-06-05](https://search.stillhousedata.com/formd/0001140361-18-027299) | D | $3.0M | $3.0M |
| [2016-05-24](https://search.stillhousedata.com/formd/0001140361-16-066781) | D | $1.5M | $750K |

## More

- [CIK 1555192 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1555192&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001140361-12-034377.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.